0001144204-18-016700.txt : 20180323 0001144204-18-016700.hdr.sgml : 20180323 20180323161855 ACCESSION NUMBER: 0001144204-18-016700 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180319 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180323 DATE AS OF CHANGE: 20180323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTH DISCOVERY CORP CENTRAL INDEX KEY: 0001141788 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 743002154 STATE OF INCORPORATION: 2Q FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-62216 FILM NUMBER: 18710322 BUSINESS ADDRESS: STREET 1: 4243 DUNWOODY CLUB DRIVE STREET 2: SUITE #202 CITY: ATLANTA STATE: GA ZIP: 30350 BUSINESS PHONE: (678)336-5300 MAIL ADDRESS: STREET 1: 4243 DUNWOODY CLUB DRIVE STREET 2: SUITE #202 CITY: ATLANTA STATE: 2Q ZIP: 31401 FORMER COMPANY: FORMER CONFORMED NAME: DIRECT WIRELESS COMMUNICATIONS INC DATE OF NAME CHANGE: 20010531 8-K 1 tv489427_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 19, 2018

Health Discovery Corporation

(Exact name of registrant as specified in charter)

Georgia

333-62216

74-3002154

(State of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

4243 Dunwoody Club Drive, Suite 202, Atlanta GA 30350

(Address of principal executive offices / Zip Code)

(678) 336-5300

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	¨	Written communications pursuant to Rule 425 under the Securities Act.
	¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
	¨	Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
	¨	Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

ITEM 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 19, 2018, Mr. Kevin Kowbel resigned as a Director of Health Discovery Corporation. A copy of Mr. Kowbel’s resignation notice is attached to this Form 8-K as Exhibit 99.1.

Item 9.01.

Financial Statements and Exhibits.

(a)	Not applicable
(b)	Not applicable
(c)	Not applicable
(d)	Exhibits.

99.1

Resignation Notice of Mr. Kevin Kowbel

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HEALTH DISCOVERY CORPORATION



Dated: March 23, 2018	By:	/s/ George H. McGovern, III
		George H. McGovern, III
		Chairman & Chief Executive Officer

EX-99.1 2 tv489427_ex99-1.htm EXHIBIT 99.1

EXHIBIT 99.1

March 19, 2018

Health Discovery Corporation

VIA Email

I respectfully resign from my board position with Health Discovery Corporation. I wish the company good luck with it future endeavors.

/s/ Kevin Kowbel, P.Eng.